ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

NEXI NexImmune Inc

3.06
0.00 (0.00%)
Jun 02 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 3.01
Ask Price 3.20
News -
Day High

Low
1.2501

52 Week Range

High
28.405

Day Low
Share Name Share Symbol Market Stock Type
NexImmune Inc NEXI NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 3.06 19:00:00
Open Price Low Price High Price Close Price Previous Close
3.06
Trades Shares Traded Average Volume 52 Week Range
0 0 - 1.2501 - 28.405
Last Trade Type Quantity Price Currency
- 0 US$ 3.06 USD

NexImmune Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
3.24M 1.06M - 0 -32.34M -30.57 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

NexImmune News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NEXI Message Board. Create One! See More Posts on NEXI Message Board See More Message Board Posts

Historical NEXI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.183.183.013.054,083-0.12-3.77%
1 Month3.413.8353.013.4114,099-0.35-10.26%
3 Months5.896.233.014.4728,560-2.83-48.05%
6 Months4.5928.4052.0728.851,138,113-1.53-33.33%
1 Year9.45528.4051.25018.38687,199-6.40-67.64%
3 Years460.25484.251.250127.37553,890-457.19-99.34%
5 Years575.25695.001.250136.91511,606-572.19-99.47%

NexImmune Description

NexImmune Inc is a clinical-stage biotechnology company engaged in developing immunotherapy to employ the body's T cells to generate an immune response that mimics natural biology. It creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases.